Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Direct to consumer genetic health tests are popular but is taking one a good idea? We brought in genetics counselor Karin Dent to explain the realities of at-home genetics testing and why it’s ...
For diseases like depression, finding medications that work well for patients can be a long, arduous journey. Genetic tests now claim to speed it along by giving doctors more information about how ...
Dyslexia is a developmental disorder characterized by severe problems in the acquisition of reading and writing skills. It has a strong neurobiological basis. Genetic influence is estimated at 50–70%.
The introduction of new genetic tests, like other medical innovations, can be conceptualized as a three-step process. Tests are proposed for use based on research findings and clinical reasoning; an ...
Myriad Genetics, Inc.’s MYGN GeneSight pharmacogenomics test was recently rolled out with Integrated Prescription Management (IPM), a pharmacy benefits management (PBM) company. Notably, the IPM will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results